Browsing by Issue Date, starting with "2019-03-29"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- Papuloerythroderma of Ofuji: First Case Report in PortugalPublication . Raposo, I.; Sanches, M.; Ferreira, S.; Selores, M.
- Ustekinumab in Real-Life Practice: Experience in 116 Patients with Moderate-To-Severe PsoriasisPublication . Raposo, I.; Bettencourt, A.; Leite, L.; Selores, M.; T, TorresUstekinumab is a monoclonal antibody directed against the p40 subunit common to both IL-12 and IL-23 cytokines. Although the evidence of ustekinumab efficacy and safety in clinical trials is extensively recognized, data on its use in clinical practice is limited. Our objective is to report on the real-life experience of two Portuguese dermatology departments with ustekinumab in patients with moderate to severe psoriasis, and to identify the clinical characteristics associated with a weaker clinical response.